# Patent Versus Generic Clopidogrel in Acute Coronary Syndrome

> **NCT02628587** · PHASE4 · UNKNOWN · sponsor: **Hospital Central San Luis Potosi, Mexico** · enrollment: 60 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Generic clopidogrel
- **DRUG:** Patent clopidogrel

## Key facts

- **NCT ID:** NCT02628587
- **Lead sponsor:** Hospital Central San Luis Potosi, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02628587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02628587, "Patent Versus Generic Clopidogrel in Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02628587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*